US Stock MarketDetailed Quotes

AZN AstraZeneca

Watchlist

63.510 -0.080-0.13% Close 12/07 16:00 ET

64.070+0.560+0.88% Pre 05:28 ET

63.820High63.070Low6.19MVolume

AstraZeneca Stock Forum

Moomoo AI

12/06 15:36

Despite the underperformance of healthcare stocks, strategists and advisors see earning potential due to attractive valuations and innovative advances. Stocks like Johnson & Johnson, AbbVie, and AstraZeneca could leverage their product portfolios for growth.

Pharma Stocks With Nice Dividends: The RX Investors Need -- Barrons.com

Meltyy

12/05 16:56

Roche Acquires Carmot Therapeutics in $2.7 Billion Deal to Enter Obesity Drug Market

Details:
Roche agrees to buy obesity drug developer Carmot Therapeutics for an upfront $2.7 billion, eyeing competition with Novo Nordisk and Eli Lilly.
Carmot's key drug candidate, CT-388, shows promise as a dual GLP-1/GIP receptor agonist, similar to Lilly's Mounjaro.
CT-388, currently ready for Phase II trials, could potentially hit the market in the 2030s.
Roche shares rise 2.4%, with analysts optimistic abou...

Moomoo AI

11/14 14:32

Late to the game, the firm sees EC5004, inexpensive and simplistically designed, as a pivotal weight management tool. They're planning not just weight loss trials but also cardiovascular studies. AstraZeneca's management predicts the market, large enough, can support multiple products.

AstraZeneca Targets New Pill as Cheaper Option for Losing a 'Bit of Weight' -- Barrons.com

Alvinnnnnnn89

11/10 11:06

Wow huge buy

$AstraZeneca(AZN.US)$

Moomoo AI

11/10 00:08

Analysts consider AstraZeneca's move into the weight-loss drug sector a positive sign, though it trails behind competitors Novo Nordisk and Eli Lilly. BMO Capital Markets analyst Etzer Darout maintains an Outperform rating and an $83 target price on AstraZeneca ADRs.

AstraZeneca Is Getting Into the Weight-Loss Drug Game. The Stock Needs a Boost. -- Barrons.com

Movers and Shakers

11/09 21:25

ColumnsToday's Morning Movers and Top Ratings: ARM, AMC, LLY, TPR and More.

Morning Movers
Gapping up
$AstraZeneca(AZN.US)$ ADRs rose 2.4% after the drugmaker raised its annual earnings forecast, helped by strong demand for its cancer drugs, and moved to boost its pipeline in the booming anti-obesity market.
$Disney(DIS.US)$ stock rose 4.1% after the entertainment giant impressed with its quarterly earnings, thanks in large part to subscriber growth at its streaming services as well as higher attendance...

Moomoo AI

11/09 18:41

Analysts at Shorecap believe that AstraZeneca shares are worthy of a premium considering its earnings growth and pipeline prospects despite trading in line with the U.S. and European peer group.

AstraZeneca Hikes Earnings Forecast as Surging Cancer Drug Sales Offset Plunging Revenue From COVID Vaccines

Moomoo AI

11/09 18:30

Reduced dependence on low-margin COVID medicines and enhanced sales from non-COVID drugs led to AstraZeneca's raised guidance for 2023 to a mid single-digit increase in total revenues.

AstraZeneca Lifts Forecast After Strong Q3, Signs $2B Deal for Obesity Drug

Movers and Shakers

09/25 20:14

ColumnsToday's Pre-Market Stock Movers and Top Ratings: AMZN, DIS, NKE, DOW and More

Pre-Market Stock Movers
Gapping up
$Amazon(AMZN.US)$ stock rose 0.5% after the tech giant announced plans to invest up to $4 billion in artificial intelligence group Anthropic, in an attempt to bolster its position in nascent AI technology.
$Warner Bros Discovery(WBD.US)$ stock rose 2.1%, $Netflix(NFLX.US)$ rose 0.8% and $Disney(DIS.US)$ rose 1.1% as these entertainment giants benefited from the news that Hollywood's wr...

Movers and Shakers

09/22 20:33

ColumnsToday's Pre-Market Stock Movers and Top Ratings: AZN, W, RL, DE and More

Pre-Market Stock Movers
Gapping up
$AstraZeneca(AZN.US)$
(Shares of the British pharmaceutical company gained more than 2.7% in premarket trading after the company reported positive results for its drug Dato-DXd in a trial for treating a common type of breast cancer.)
$Wayfair(W.US)$
(Shares gained more than 2% after Bernstein upgraded home merchandiser to market perform from underperform. The firm cited improving revenue gr...

GAME_DAY

09/12 20:32

Current watch ⚡️

$AgileThought(AGIL.US)$$AstraZeneca(AZN.US)$$NOCO-NOCO(NCNC.US)$$Sigmatron International(SGMA.US)$$Oracle(ORCL.US)$$Tenon Medical(TNON.US)$$Avalo Therapeutics(AVTX.US)$$Ascent Solar Technologies(ASTI.US)$$Acelyrin(SLRN.US)$$Aurora Cannabis(ACB.US)$

GAME_DAY

09/12 07:09

Daily alerts recap 🔥

$Biocept(BIOC.US)$$Cingulate(CING.US)$$Solowin(SWIN.US)$$Lantronix(LTRX.US)$$AGBA Group(AGBA.US)$$FuboTV(FUBO.US)$$Alphabet-C(GOOG.US)$$AstraZeneca(AZN.US)$$Victoria's Secret(VSCO.US)$

Analysts Notebook

08/30 16:27

ColumnsWhat You Need to Know About Medicare Price Negotiations

The Biden administration has announced the first ten prescription drugs that will be negotiated for lower prices between manufacturers and Medicare, in an effort to make expensive medications more affordable for older Americans. Medicare has been given the power to negotiate drug prices directly with manufacturers, the first time this has occurred in the nearly 60-year history of the federal program, through President Joe Biden's Inflation R...

Weight-loss drugmaker surpasses LVMH: What's your thought?

GAME_DAY

07/24 11:32

TOP WATCH 7/24 ⚡️⚡️

$AbbVie(ABBV.US)$$AMC Entertainment(AMC.US)$$AstraZeneca(AZN.US)$$Vinco Ventures(BBIG.US)$$Bragg Gaming Group(BRAG.US)$$CSX Corp(CSX.US)$$Digital World Acquisition Corp(DWAC.US)$$eBay(EBAY.US)$$Guardforce AI(GFAI.US)$$Interactive Brokers(IBKR.US)$$Intuitive Surgical(ISRG.US)$$JetBlue Airways(JBLU.US)$$NVIDIA(NVDA.US)$$Pfizer(PFE.US)$$Procter & Gamble(PG.US)$$Smith & Wesson Brands(SWBI.US)$
FOLLOW FOR DAILY WATCHLIST 🔥⚡️

Moomoo Recap US

07/18 04:06

ColumnsWall Street Today | Goldman’s Hatzius Cuts Odds of US Recession in Next Year to 20%

MACRO
Goldman’s Hatzius Cuts Odds of US Recession in Next Year to 20%
“We are cutting our probability that a US recession will start in the next 12 months further from 25% to 20%,” Jan Hatzius, the chief economist at Goldman Sachs Group, wrote in a report published Monday. “The main reason for our cut is that the recent data have reinforced our confidence that bringing inflation down to an acceptable level will no...

Sam Wallstreet

07/05 22:41

QUICK SCALP 67 $AZN - STOCK & OPTION PLAY
ALERT ON: $67.01
ON THE WATCH: $67.15
🥇 SIGNED OF MORE UPTREND: $67.25
NEED IT TO BREAK OVER: $67.37
key indicator for MORE uptrend $67.49
confirmation uptrend - $67.64
OK I SEE YOU - $67.78
mini breakout - $67.88
Prepare for bigger breakout: $67.95. $AstraZeneca(AZN.US)$

Unusual US Option Activity

Mooers Radar

07/04 08:29

ColumnsUS Top Gap Ups and Downs on 7/3: RIVN, TSLA, LH, ORCL and More

Here are the top gap ups and downs for the stocks with a market cap above $5 billion after market closed (gaps range from large to small):
Gap Ups
1. $Rivian Automotive(RIVN.US)$ - up 6.3%
2. $Tesla(TSLA.US)$ - up 4.0%
3. $Baidu(BIDU.US)$ - up 3.4%
4. $Fidelity National Information Services(FIS.US)$ - up 3.3%
5. $POSCO(PKX.US)$ - up 2.8%
6. $Full Truck Alliance(YMM.US)$ - up 2.1%
7. $Bilibili(BILI.US)$ - up 1.8%
8. $Li Auto(LI.US)$ - up 1.7...

+16

Movers and Shakers

07/03 20:24

ColumnsToday's Pre-Market Stock Movers And Top Ratings: TSLA, NIO, CVX, AZN and More

Pre-Market Stock Movers
Gapping up
$Tesla(TSLA.US)$ +7% (Tesla popped nearly 7% after the electric vehicle company posted second-quarter delivery and production numbers that topped Wall Street's expectations. Deliveries rose 83% year over year.)
$NIO Inc(NIO.US)$ +4.45% (Nio rose following Tesla posted strong-than-expected production and delivery numbers for the second quarter.)
$PDD Holdings(PDD.US)$ +3.23% (Pinduoduo ...